500mg Tenvir EM Tenofovir Disoproxil Fumarate Emtricitabine Tablets

500mg Tenvir EM Tenofovir Disoproxil Fumarate Emtricitabine Tablets Specification

Packaging Type
Box, blister strip

Dosage Form
Tablet

Life Span
24-36 months (as per manufacturing date)

Salt Composition
Tenofovir Disoproxil Fumarate 300 mg + Emtricitabine 200 mg

Indication
HIV-1 infection treatment and prevention (Pre-Exposure Prophylaxis)

Brand Name
Tenvir-EM

Origin of Medicine
India

Pacakaging (Quantity Per Box)
30 tablets

Drug Type
Allopathic, prescription only

Ingredients
Tenofovir Disoproxil Fumarate 300 mg, Emtricitabine 200 mg

Physical Form
Tablets

Function
Antiviral / Antiretroviral therapy

Recommended For
HIV PrEP (Pre-Exposure Prophylaxis) and HIV-1 treatment

Dosage
As directed by the physician

Dosage Guidelines
Take one tablet daily, with or without food, as prescribed

Suitable For
Adults

Storage Instructions
Store below 30C, protect from light and moisture

Contraindications
Known hypersensitivity to any component, severe renal impairment

Disposal Instructions
Dispose of unused tablets as per local regulations for pharmaceutical products

Shape
Capsule-shaped

Side Effects
Nausea, headache, fatigue, potential renal or bone effects

Warning
To be taken under medical supervision

International Brand Equivalent
Truvada

Route of Administration
Oral

Prescription Required
Yes

Inactive Ingredients
Lactose monohydrate, magnesium stearate, microcrystalline cellulose, croscarmellose sodium

Color
Blue

Regulatory Approval
WHO prequalified, US FDA approved ingredient

Patient Category
Not recommended for pediatric use below 18 years

Tablet Identification
TENOFOVIR/EMTRICITABINE debossed marking on tablet

500mg Tenvir EM Tenofovir Disoproxil Fumarate Emtricitabine Tablets Trade Information

Minimum Order Quantity
10 Pieces

Supply Ability
1000 Pieces Per Month

Delivery Time
7 Days

About 500mg Tenvir EM Tenofovir Disoproxil Fumarate Emtricitabine Tablets

Strength	300mg + 200mg
Brand	Tenvir-EM
Composition	Tenofovir Disoproxil Fumarate + Emtricitabine
Form	Tablet
Prescription/Non prescription	Prescription
Treatment	HIV infection
Packaging Size	30 Tablets
Manufacturer	Cipla Ltd

Tenvir-EM Tablet is a combination of two anti-HIV medicines: Emtricitabine and Tenofovir disoproxil fumarate. They prevent HIV (virus) from multiplying, thereby reducing the amount of virus in your body. They also increase the CD4 cell (white blood cells that protect against infection) count in your blood.

Trusted Antiviral Protection for HIV

Tenvir-EM serves dual roles-both in preventing HIV infection (PrEP) in high-risk adults and as part of combination therapy for HIV-1 treatment. With proven efficacy and US FDA-approved ingredients, this medicine has earned WHO prequalification, endorsing its safety and quality for global health applications.

Simple Dosing and Administration

Taking Tenvir-EM is straightforward: swallow one tablet daily, with or without food, as your healthcare provider directs. Do not miss doses, and always adhere to your physician's guidance. Regular follow-up with your doctor ensures safety and effectiveness throughout your therapy.

Clear Identification and Compliance

Each tablet is blue, capsule-shaped, and marked with 'TENOFOVIR/EMTRICITABINE' for easy identification. Supplied as a box of 30 tablets, it supports a consistent one-month supply. Store below 30C, in a dry place, and keep away from direct sunlight to maintain efficacy.

FAQ's of 500mg Tenvir EM Tenofovir Disoproxil Fumarate Emtricitabine Tablets:

Q: What is Tenvir-EM used for?

A: Tenvir-EM is indicated for the treatment and prevention of HIV-1 infection. It is used as part of antiretroviral therapy and as pre-exposure prophylaxis (PrEP) in adults at substantial risk of HIV-1 infection.

Q: How should Tenvir-EM tablets be taken?

A: The recommended dosage is one tablet daily, taken orally with or without food, exactly as prescribed by your healthcare provider. Do not skip doses, and consult your doctor for ongoing monitoring.

Q: Who should not take Tenvir-EM?

A: Tenvir-EM should not be used by individuals with known hypersensitivity to any of its components, those with severe renal impairment, or by persons under 18 years old. Medical supervision is essential before starting therapy.

Q: What side effects may occur with Tenvir-EM?

A: Common side effects include nausea, headache, and fatigue. Potentially, it may cause renal or bone effects. Notify your healthcare provider if you experience persistent or severe symptoms.

Q: Where should Tenvir-EM tablets be stored?

A: Store the tablets below 30C, protected from moisture and light, in their original packaging. Keep them out of reach of children and dispose of unused tablets following local pharmaceutical waste regulations.

Q: When should I start or stop using Tenvir-EM for HIV prevention?

A: Tenvir-EM should always be started or discontinued under the guidance of a healthcare professional, based on individual risk and laboratory assessments. Do not stop taking the medication abruptly without medical advice.

Q: What are the benefits of using Tenvir-EM for PrEP?

A: When taken consistently, Tenvir-EM significantly reduces the risk of acquiring HIV-1 infection in adults at high risk, providing an effective preventive option as part of a comprehensive HIV prevention strategy.